Luceome Biotechnologies

Tucson, United States Founded: 2007 • Age: 19 yrs
Assay technology is developed for identifying drugs against kinases.
Annual revenue - Latest available
Total funding - 15 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 3 Services tracked
Competitors 9 Brand Intelligence

About Luceome Biotechnologies

Luceome Biotechnologies is a company based in Tucson (United States) founded in 2007. Luceome Biotechnologies offers products and services including Cell-free KinaseSeeker Assays, Cell-based KinaseSeeker-TE Assays, and Custom Assay Development. Luceome Biotechnologies operates in a competitive market with competitors including Alamar Biosciences, Harmonic Discovery, Glympse Bio, Seahorse Bioscience and BiOD, among others.

  • Headquarter Tucson, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Luceome Biotechnologies, L.L.C.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $240.43 K (USD), Grant

    Apr 01, 2022

  • Investors
    NIH

    & 1 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Luceome Biotechnologies

Luceome Biotechnologies offers a comprehensive portfolio of products and services, including Cell-free KinaseSeeker Assays, Cell-based KinaseSeeker-TE Assays, and Custom Assay Development.

Product name locked
Category locked
Primary

Profiles compound selectivity in vitro against kinase panels.

Product name locked
Category locked
Locked

Evaluates compound target engagement inside cells for potency.

Product name locked
Category locked
Locked

Tailors luciferase assays for in-house inhibitor screening needs.

Funding Insights of Luceome Biotechnologies

Investors in Luceome Biotechnologies

Luceome Biotechnologies has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Locked Locked Locked
Drug discovery services are provided to the biopharma sector.
Locked Locked Locked
Premium access

Investor details for Luceome Biotechnologies

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Luceome Biotechnologies

Investments
Premium access

Investment portfolio details for Luceome Biotechnologies

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Luceome Biotechnologies

Premium access

Detailed financials for Luceome Biotechnologies

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Luceome Biotechnologies Comparisons

Luceome Biotechnologies Primary company
Description
Assay technology is developed for identifying drugs against ...
Location
Tucson, United States
Founded Year
2007
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Luceome Biotechnologies

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Luceome Biotechnologies

Luceome Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alamar Biosciences, Harmonic Discovery, Glympse Bio, Seahorse Bioscience and BiOD, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Ultra-high sensitivity protein analysis solutions are provided across multiplex levels.
Locked Locked Locked
Developer of kinase inhibitor drugs for oncology
Locked Locked Locked
Multiple human diseases are monitored noninvasively through urine-based analysis.
Locked Locked Locked
Cellular metabolic status is measured via the Seahorse XFp Analyzer.
Locked Locked Locked
Develops innovative in-vitro diagnostic platforms using optical interrogation of biochip-kits.
Premium access

Detailed competitors of Luceome Biotechnologies

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Luceome Biotechnologies

Premium access

Complete news archive for Luceome Biotechnologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Luceome Biotechnologies

Luceome Biotechnologies was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Luceome Biotechnologies is headquartered in Tucson, United States. It is registered at Tucson, Arizona, United States.

Luceome Biotechnologies was founded in 2007 in Tucson, United States, within the biotechnology sector. Assay technology is developed for drug discovery targeting kinases. Solutions including KinaseSeeker and KinaseLite are provided, based on a platform using luciferase fragment complementation. Luminescence from this process is used to detect target interactions and off-target effects of drug candidates.

Luceome Biotechnologies's top competitors include Alamar Biosciences, Glympse Bio and Harmonic Discovery.

Luceome Biotechnologies offers Cell-free KinaseSeeker Assays, Cell-based KinaseSeeker-TE Assays, and Custom Assay Development.

Luceome Biotechnologies has 2 investors. Key investors include NIH, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available